Dyne Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 11/13/2024 | 9.03 M | $324.24 M | 69.71% | 8.95% |
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 11/13/2024 | 8.02 M | $288.08 M | 0.00% | 7.95% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 7.79 M | $279.96 M | 100.00% | 7.73% |
VANGUARD GROUP INC | 11/13/2024 | 6.86 M | $246.56 M | 45.49% | 6.80% |
RTW INVESTMENTS, LP | 11/14/2024 | 6.82 M | $244.93 M | 6.76% | 6.76% |
JANUS HENDERSON GROUP PLC | 11/14/2024 | 6.81 M | $244.76 M | 47.35% | 6.75% |
RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 6.38 M | $229.21 M | 5.49% | 6.33% |
FCPM III SERVICES B.V. | 11/14/2024 | 5.95 M | $213.87 M | -24.11% | 5.90% |
STATE STREET CORP | 11/14/2024 | 3.64 M | $130.82 M | 13.77% | 3.61% |
DEEP TRACK CAPITAL, LP | 11/14/2024 | 3.28 M | $117.89 M | -17.95% | 3.25% |
CITADEL ADVISORS LLC | 11/14/2024 | 2.94 M | $105.58 M | -31.90% | 2.91% |
TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 2.65 M | $95.19 M | 0.00% | 2.63% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 2.64 M | $94.70 M | 11.42% | 2.61% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 2.40 M | $86.31 M | -27.80% | 2.38% |
VR ADVISER, LLC | 11/14/2024 | 2.17 M | $78.09 M | 0.00% | 2.15% |
HOLOCENE ADVISORS, LP | 11/14/2024 | 1.98 M | $71.22 M | -4.51% | 1.97% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.86 M | $66.80 M | 4.78% | 1.84% |
JENNISON ASSOCIATES LLC | 11/08/2024 | 1.35 M | $48.38 M | 1.49% | 1.34% |
FRANKLIN RESOURCES INC | 11/27/2024 | 1.34 M | $44.72 M | -21.70% | 1.33% |
FIRST LIGHT ASSET MANAGEMENT, LLC | 11/14/2024 | 1.26 M | $45.16 M | 228.76% | 1.25% |
ARMISTICE CAPITAL, LLC | 11/14/2024 | 1.16 M | $41.49 M | 18.98% | 1.15% |
SIREN, L.L.C. | 11/13/2024 | 1.13 M | $40.76 B | 100.00% | 1.12% |
VIVO CAPITAL, LLC | 11/13/2024 | 1.11 M | $40.05 M | -31.81% | 1.11% |
MORGAN STANLEY | 11/14/2024 | 1.05 M | $37.83 M | 88.40% | 1.04% |
WOODLINE PARTNERS LP | 11/14/2024 | 977,440 | $35.11 M | -20.79% | 0.97% |
ARROWMARK COLORADO HOLDINGS LLC | 11/14/2024 | 900,190 | $32.33 M | -2.09% | 0.89% |
SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 772,070 | $27.73 B | -52.51% | 0.77% |
MAN GROUP PLC | 11/14/2024 | 718,650 | $25.81 M | 100.00% | 0.71% |
PERCEPTIVE ADVISORS LLC | 11/14/2024 | 718,144 | $25.80 M | 100.00% | 0.71% |
ORBIMED ADVISORS LLC | 11/14/2024 | 708,400 | $25.45 M | 0.00% | 0.70% |
MPM ASSET MANAGEMENT LLC | 11/13/2024 | 682,376 | $24.51 M | -56.30% | 0.68% |
BAKER BROS. ADVISORS LP | 11/14/2024 | 672,096 | $24.14 M | 0.00% | 0.67% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 670,484 | $24.08 M | -68.01% | 0.66% |
AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 650,000 | $23.35 M | 461.55% | 0.64% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 648,652 | $23.30 M | 7.92% | 0.64% |
UBS GROUP AG | 11/14/2024 | 625,719 | $22.48 M | 156.52% | 0.62% |
ECOR1 CAPITAL, LLC | 11/14/2024 | 555,644 | $19.96 M | 30.12% | 0.55% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 461,028 | $16.56 M | 0.00% | 0.46% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 435,653 | $15.65 M | 100.00% | 0.43% |
FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 428,000 | $15.37 M | 7,033.33% | 0.42% |
VIDA VENTURES ADVISORS, LLC | 10/08/2024 | 407,499 | $14.64 M | 0.00% | 0.40% |
CANDRIAM S.C.A. | 11/13/2024 | 390,956 | $14.04 M | -26.69% | 0.39% |
EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 332,277 | $11.94 M | -31.49% | 0.33% |
WASATCH ADVISORS LP | 11/14/2024 | 324,099 | $11.64 M | -3.43% | 0.32% |
ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 312,752 | $11.23 M | 0.00% | 0.31% |
PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 304,705 | $10.32 M | 3.38% | 0.30% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 291,712 | $10.48 M | 65.02% | 0.29% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 276,414 | $9.93 M | -56.38% | 0.27% |
OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 262,726 | $9.44 M | -77.75% | 0.26% |
VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 248,320 | $8.92 M | -2.33% | 0.25% |
Dyne Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 238 institutional investors and hedge funds held shares of Dyne Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 9.03 M
Atlas Venture Life Science Advisors, LLC: 8.02 M
BlackRock Funding, Inc. /DE: 7.79 M
VANGUARD GROUP INC: 6.86 M
RTW INVESTMENTS, LP: 6.82 M
JANUS HENDERSON GROUP PLC: 6.81 M
111.02% of Dyne Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 117.59 M shares in the last 24 months. This purchase volume represents approximately $2.88 B in transactions.